{"title":"Association Between Benign Thyroid Disorders and Breast Cancer Risk in Korean Women.","authors":"Boyoung Park, Thi Xuan Mai Tran","doi":"10.4143/crt.2024.787","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the potential association between thyroid disorders and breast cancer (BC) risk in a cohort of Korean women.</p><p><strong>Materials and methods: </strong>Data for this retrospective cohort study were obtained from the Korean National Health Insurance database, including all women aged ≥ 40 who underwent BC screening from 2009 to 2010 in Korea. Thyroid disorders were identified using medical records from 2009 to 2010 and extracted using the ICD-10 codes for thyroid nodules, hypothyroidism, and hyperthyroidism. BC cases were defined using the ICD-10 codes and tracked until December 2021. A Cox regression model was used to evaluate the association between thyroid disorders and the risk of BC. Additionally, we evaluated the association between well-known risk factors of BC and thyroid disorders using logistic regression analysis.</p><p><strong>Results: </strong>Among 5,051,633 women, the mean (standard deviation) age was 55.2 (10.7) years, and the median follow-up was 11.6 years, with 87,784 BC cases recorded. The proportions of patients with thyroid nodules, hypothyroidism, and hyperthyroidism were 2.5, 1.8, and 0.9%, respectively. The hazard ratio (HR) for BC risk associated with thyroid nodules was 1.16 (95% CI 1.11-1.20), for hypothyroidism was 0.98 (95% CI 0.93-1.03), and for hyperthyroidism was 1.13 (95% CI 1.06-1.21). In both premenopausal and postmenopausal women, an increased risk of BC was significantly associated with thyroid nodules (aHR 1.16 and 1.13) and hyperthyroidism (aHR 1.11 and 1.16). History of benign breast disease, oral contraceptive use, breastfeeding, menopausal status, and hormone replacement therapy were associated with thyroid nodules and hyperthyroidism.</p><p><strong>Conclusion: </strong>Our findings suggest an increased risk of BC in women with a history of thyroid nodules and hyperthyroidism, whereas no such association was found in women with hypothyroidism.</p>","PeriodicalId":49094,"journal":{"name":"Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4143/crt.2024.787","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究旨在调查韩国女性队列中甲状腺疾病与乳腺癌(BC)风险之间的潜在关联:这项回顾性队列研究的数据来自韩国国民健康保险数据库,其中包括2009年至2010年期间在韩国接受乳腺癌筛查的所有年龄≥40岁的女性。通过 2009 年至 2010 年的医疗记录确定甲状腺疾病,并使用 ICD-10 编码提取甲状腺结节、甲状腺功能减退症和甲状腺功能亢进症。使用 ICD-10 编码定义 BC 病例,并追踪至 2021 年 12 月。我们采用 Cox 回归模型来评估甲状腺疾病与 BC 风险之间的关系。此外,我们还利用逻辑回归分析评估了众所周知的乳腺癌风险因素与甲状腺疾病之间的关联:在5,051,633名女性中,平均(标准差)年龄为55.2(10.7)岁,中位随访时间为11.6年,共记录了87,784例BC。甲状腺结节、甲状腺功能减退和甲状腺功能亢进患者的比例分别为2.5%、1.8%和0.9%。与甲状腺结节相关的 BC 风险危险比 (HR) 为 1.16 (95% CI 1.11-1.20),与甲状腺功能减退症相关的风险危险比 (HR) 为 0.98 (95% CI 0.93-1.03),与甲状腺功能亢进症相关的风险危险比 (HR) 为 1.13 (95% CI 1.06-1.21)。在绝经前和绝经后妇女中,甲状腺结节(aHR 1.16 和 1.13)和甲状腺机能亢进(aHR 1.11 和 1.16)显著增加了罹患乳腺癌的风险。良性乳腺疾病史、口服避孕药、母乳喂养、绝经状态和激素替代疗法与甲状腺结节和甲状腺功能亢进有关:我们的研究结果表明,有甲状腺结节和甲状腺机能亢进病史的妇女罹患乳腺癌的风险增加,而甲状腺机能减退的妇女罹患乳腺癌的风险则没有增加。
Association Between Benign Thyroid Disorders and Breast Cancer Risk in Korean Women.
Purpose: This study aimed to investigate the potential association between thyroid disorders and breast cancer (BC) risk in a cohort of Korean women.
Materials and methods: Data for this retrospective cohort study were obtained from the Korean National Health Insurance database, including all women aged ≥ 40 who underwent BC screening from 2009 to 2010 in Korea. Thyroid disorders were identified using medical records from 2009 to 2010 and extracted using the ICD-10 codes for thyroid nodules, hypothyroidism, and hyperthyroidism. BC cases were defined using the ICD-10 codes and tracked until December 2021. A Cox regression model was used to evaluate the association between thyroid disorders and the risk of BC. Additionally, we evaluated the association between well-known risk factors of BC and thyroid disorders using logistic regression analysis.
Results: Among 5,051,633 women, the mean (standard deviation) age was 55.2 (10.7) years, and the median follow-up was 11.6 years, with 87,784 BC cases recorded. The proportions of patients with thyroid nodules, hypothyroidism, and hyperthyroidism were 2.5, 1.8, and 0.9%, respectively. The hazard ratio (HR) for BC risk associated with thyroid nodules was 1.16 (95% CI 1.11-1.20), for hypothyroidism was 0.98 (95% CI 0.93-1.03), and for hyperthyroidism was 1.13 (95% CI 1.06-1.21). In both premenopausal and postmenopausal women, an increased risk of BC was significantly associated with thyroid nodules (aHR 1.16 and 1.13) and hyperthyroidism (aHR 1.11 and 1.16). History of benign breast disease, oral contraceptive use, breastfeeding, menopausal status, and hormone replacement therapy were associated with thyroid nodules and hyperthyroidism.
Conclusion: Our findings suggest an increased risk of BC in women with a history of thyroid nodules and hyperthyroidism, whereas no such association was found in women with hypothyroidism.
期刊介绍:
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.